United Services Automobile Association Madrigal Pharmaceuticals, Inc. Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 16, 2019	SELL	$91.13 - $142.5 $156,743 - $245,100	-1,720 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$103.48 - $143.84 $17,695 - $24,596	-171 Reduced 9.04%	1,720 $215,000
Q4 2018 Feb 13, 2019	BUY	$94.77 - $215.54 $11,846 - $26,942	125 Added 7.08%	1,891 $213,000
Q3 2018 Nov 13, 2018	SELL	$207.3 - $300.31 $8,084 - $11,712	-39 Reduced 2.16%	1,766 $378,000
Q2 2018 Aug 10, 2018	BUY	$101.55 - $313.9 $183,297 - $566,589	1,805 New	1,805 $505,000

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.